Gene therapy using ‘junk DNA’ could lower risk for heart disease – Medical Xpress
Medical Xpress |
Gene therapy using ‘junk DNA’ could lower risk for heart disease
Medical Xpress Scientists from UCLA and the Howard Hughes Medical Institute successfully used a gene that suppresses cholesterol levels as part of a treatment to reduce … Familial Hypercholesterolemia: “Junk” RNA May Facilitate Gene …MedicalResearch.com (blog) |
|
FDA Raids One Stem Cell Lab and Warns Another in Regulatory Push
Bloomberg On Monday, the Food and Drug Administration released a warning letter it sent last week to Florida-based U.S. Stem Cell Inc. for selling unapproved stem–cell treatments and injecting them into patients’ spinal cords. And it raided a San Diego-based … |
FierceBiotech |
CSL Behring buys Calimmune for early stem cell, gene therapy boost
FierceBiotech CSL Behring has paid out $91 million upfront for biotech Calimmune and gains a preclinical asset for sickle cell disease and β-thalassemia, adding to its blood disease pipeline. The biotech is working on ex vivo hematopoietic stem cell (HSC) gene … CSL snags a preclinical stem cell therapy in $416M Calimmune buyout, plans to spin out HIV effortEndpoints News CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy PlatformMarkets Insider CSL spends $114m to buy US cell and gene therapy companyThe Australian |
FierceBiotech |
CSL Behring buys Calimmune for early stem cell, gene therapy boost
FierceBiotech CSL Behring has paid out $91 million upfront for biotech Calimmune and gains a preclinical asset for sickle cell disease and β-thalassemia, adding to its blood disease pipeline. The biotech is working on ex vivo hematopoietic stem cell (HSC) gene … CSL snags a preclinical stem cell therapy in $416M Calimmune buyout, plans to spin out HIV effortEndpoints News CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy PlatformMarkets Insider CSL spends $114m to buy US cell and gene therapy companyThe Australian |
|
FDA acts to remove unproven, potentially harmful treatment used in ‘stem cell‘ centers targeting vulnerable patients
PR Newswire (press release) The seizure comes after recent FDA inspections at StemImmune Inc. and the California Stem Cell Treatment Centers confirmed that the vaccine was used to create an unapproved stem cell product (a combination of excess amounts of vaccine and stromal … |
EurekAlert (press release) |
Gene therapy using ‘junk DNA’ could lower risk for heart disease
EurekAlert (press release) Although previous research has shown that lncRNAs can be important, this is the first study to show that they could potentially be used to treat a human disease using gene therapy. Junk genes could one day offer a framework for treating people with … |